Keyphrases
GammaTile
70%
Brachytherapy
58%
Treatment Planning System
56%
FDSOI
52%
Brain Metastases
52%
Treatment Volume
44%
Glioblastoma
36%
Head-and-neck
36%
Dose Prescription
35%
In Cancer
35%
Cone-beam CT
35%
KV-CBCT
35%
Silicon-on-insulator
35%
Stereotactic Radiosurgery
35%
Treatment Plan
33%
Treatment Planning
32%
Radiosurgery
27%
Patient Treatment
27%
Wireless Radiation
27%
Variable Capacitor
27%
Dosimetry
26%
Target Coverage
24%
Chemoradiation
24%
Newly Diagnosed
23%
Isocenter
22%
Clinical Trials
22%
Cancer Patients
21%
Pelvis
21%
Newly Diagnosed Glioblastoma
21%
Passive Wireless Sensor
21%
Recurrent Glioblastoma
21%
Imaging Dose
21%
Kilovoltage
21%
Photothermal Therapy
19%
Cancer Therapy
19%
Radiation Therapy
17%
Gastric Cancer
17%
Macula
17%
Improved Survival
17%
Peripheral Leukocytes
17%
Adjuvant Chemotherapy
17%
Radiation Detectors
17%
Thread Shape
17%
Collaborative Ocular Melanoma Study
17%
Eye Plaque
17%
Optical Lens
17%
Lymph Node Positive
17%
Institutional Experience
17%
Multi-institutional
17%
Optic Disc
17%
Medicine and Dentistry
Treatment Planning
100%
Brachytherapy
76%
Glioblastoma
61%
Volume CT
52%
Brain Metastasis
52%
Brain Implant
35%
Stereotactic Radiosurgery
35%
Radiation Therapy
33%
Neoplasm
30%
Radiosurgery
28%
Clinical Trial
27%
Pelvis
27%
Chemoradiotherapy
26%
Neck
22%
Isocenter
22%
Recurrent Disease
21%
Magnetic Resonance Imaging
20%
Surgery
20%
Cone Beam Computed Tomography
17%
Head and Neck Cancer
17%
Eye Melanoma
17%
Bone Density
17%
Multimodality Imaging
17%
Retrospective Study
17%
Cancer Localization
17%
Dose Calculation
17%
Optic Disc
17%
Likert Scale
17%
Tomotherapy
17%
Malignant Neoplasm
17%
Laser Surgery
17%
Squamous Cell
17%
Gamma Knife Radiosurgery
17%
Hypofractionated Radiotherapy
17%
Leukocyte
17%
Dual Energy Computed Tomography
17%
Surgery
17%
Dosimetry
14%
Intracranial Tumor
14%
Drug Megadose
13%
Kaplan Meier Method
13%
Cancer Therapy
13%
Cohort Analysis
13%
Positron Emission Tomography-Computed Tomography
12%
Medical Physicist
11%
Radiation Oncologist
11%
Overall Survival
11%
Cesium 131
11%
Patient Positioning
11%
Tumor Progression
10%